Editas Medicine, Inc. ( EDIT) - Key Metrics
EDIT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.28 | -$0.06 | -$0.41 | -$0.41 |
| 2025Q3 | $0.08 | -$0.28 | -$0.34 | -$0.35 |
| 2025Q2 | $0.04 | -$0.63 | -$0.59 | -$0.59 |
| 2025Q1 | $0.06 | -$0.92 | -$0.58 | -$0.58 |
EDIT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.09 |
| 2025Q3 | ? | -3.11 |
| 2025Q2 | ? | -0.87 |
| 2025Q1 | ? | -0.32 |
EDIT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -9.58% | ? |
| 2025Q4 | -20.03% | ? |
| 2025Q3 | -10.00% | ? |
| 2025Q2 | -27.04% | ? |
| 2025Q1 | -49.73% | ? |
EDIT
Price: $2.36
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.6 million
Ebitda: -26.1 millionMarket Capitalization: 276.1 million